Signaling Pathway
Cinpanemab (BIIB054) is a human-derived monoclonal antibody specifically designed to target ??-synuclein. This antibody has significant applications in the research of Parkinson's disease, providing a valuable tool for investigating the pathophysiology and potential therapeutic interventions targeting ??-synuclein aggregation.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Cinpanemab (BIIB054) is a human-derived monoclonal antibody specifically designed to target ??-synuclein. This antibody has significant applications in the research of Parkinson's disease, providing a valuable tool for investigating the pathophysiology and potential therapeutic interventions targeting ??-synuclein aggregation. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
